CLINICAL_TRIALS
trial_result
· 2022-08-26
Clinical Trial Update: A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection [Phase 2]
Summary
Phase 2 trial update for regimens containing ABI-H2158 in chronic hepatitis B; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: TERMINATED | Results posted: 2022-08-26